Author

John Moss

Unknown affiliation - Cited by 14,371

Biography

John Moss is currently working as a Professor in the Department of Neurology. His research interests includes Neurology, Virology. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his  Administrative responsibilities. John Moss has authored of many research articles/books related to Neurology and VIrology.  
Title
Cited by
Year
Nutrition in the acute phase of critical illness
MP Casaer, G Van den BergheNew England Journal of Medicine 370 (13), 1227-1236, 2014201
386
2014
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
JK Han, C Bachert, W Fokkens, M Desrosiers, M Wagenmann, SE Lee, ...The Lancet Respiratory Medicine 9 (10), 1141-1153, 2021202
240
2021
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer
FE Lennon, T Mirzapoiazova, B Mambetsariev, VA Poroyko, R Salgia, ...PloS one 9 (3), e91577, 2014201
193
2014
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis
FE Lennon, T Mirzapoiazova, B Mambetsariev, R Salgia, J Moss, ...The Journal of the American Society of Anesthesiologists 116 (4), 857-867, 2012201
179
2012
The μ-opioid receptor in cancer progression: is there a direct effect?
FE Lennon, J Moss, PA Singleton, B RiouThe Journal of the American Society of Anesthesiologists 116 (4), 940-945, 2012201
176
2012
Increased μ-opioid receptor expression in metastatic lung cancer
PA Singleton, T Mirzapoiazova, R Hasina, R Salgia, J MossBritish journal of anaesthesia 113 (suppl_1), i103-i108, 2014201
140
2014
119
2012
Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer
F Janku, LK Johnson, DD Karp, JT Atkins, PA Singleton, J MossAnnals of Oncology 27 (11), 2032-2038, 2016201
94
2016
The mu opioid receptor: a new target for cancer therapy?
PA Singleton, J Moss, DD Karp, JT Atkins, F JankuCancer 121 (16), 2681-2688, 2015201
78
2015
Commonly used dietary supplements on coagulation function during surgery
CZ Wang, J Moss, CS YuanMedicines 2 (3), 157-185, 2015201
54
2015
Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients
SB Sawh, IP Selvaraj, A Danga, AL Cotton, J Moss, PB PatelMayo Clinic Proceedings 87 (3), 255-259, 2012201
53
2012
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
J Moss, M Lingen, PA Singleton, JGN Garcia, CS YuanUS Patent 8,524,731, 2013201
43
2013
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
J Moss, M Lingen, PA Singleton, JGN GarciaUS Patent 9,662,390, 2017201
41
2017
Randomized clinical trial of a sustained-exposure ciprofloxacin for intratympanic injection during tympanostomy tube surgery
EA Mair, JR Moss, JE Dohar, PJ Antonelli, M Bear, C LeBelAnnals of Otology, Rhinology & Laryngology 125 (2), 105-114, 2016201
15
2016
Phase 3 trials of thermosensitive ciprofloxacin gel for middle ear effusion in children with tubes
AH Park, DR White, JR Moss, M Bear, C LeBelOtolaryngology–Head and Neck Surgery 5 (2), 324-331, 2016201
15
2016
In‐office tympanostomy tube placement in children using iontophoresis and automated tube delivery
LR Lustig, A Ingram, DM Vidrine, AR Gould, JW Zeiders, RA Ow, ...The Laryngoscope 130, S1-S9, 2020202
12
2020
Modulation of Cell Barrier Dysfunction
JC Alverdy, J Moss, MW Lingen, PA Singleton, JGN GarciaUS Patent App. 13/483,932, 202
12
2012
In-office tympanostomy tube placement using iontophoresis and automated tube delivery systems
DM Yen, MT Murray, R Puchalski, AR Gould, J Ansley, RA Ow, JR Moss, ...OTO open 4 (1), 2473974X20903125, 2020202
8
2020